Related Experiment Videos
The Fanconi anemia polypeptide, FAC, binds to the cyclin-dependent kinase, cdc2
G M Kupfer1, T Yamashita, D Naf
1Division of Pediatric Oncology and Cellular and Molecular Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Blood
|August 1, 1997
Summary
Fanconi anemia (FA) protein FAC binds to cdc2, regulating cell cycle progression. This interaction is crucial for normal G2/M phase, and its absence may cause FA cellular defects.
Area of Science:
- Genetics
- Molecular Biology
- Cell Biology
Background:
- Fanconi anemia (FA) is an inherited disorder causing bone marrow failure and cancer.
- FA cells exhibit cell cycle abnormalities, particularly a prolonged G2 phase.
- The function of the Fanconi anemia complementation group C (FAC) protein is not fully understood.
Purpose of the Study:
- To elucidate the molecular function of the FAC polypeptide.
- To investigate the role of FAC in cell cycle regulation.
- To determine the interaction between FAC and cell cycle proteins.
Main Methods:
- Synchronized HeLa cell cultures were used to study FAC expression during the cell cycle.
- Coimmunoprecipitation assays were performed to assess the interaction between FAC and cdc2.
- Mutant forms of FAC were analyzed for their binding capacity to cdc2.
Main Results:
- FAC protein expression levels varied with the cell cycle, peaking at the G2/M transition.
- FAC was found to coimmunoprecipitate with cdc2, a key cell cycle kinase.
- A patient-derived mutation (L554P) abolished FAC binding to cdc2, correlating with loss of function.
- The C-terminal 50 amino acids of FAC were identified as essential for cdc2 binding.
Conclusions:
- The binding interaction between FAC and cdc2 is essential for normal G2/M phase progression in mammalian cells.
- Dysfunctional FAC-cdc2 interaction in FA patients may explain the observed cell cycle and clinical abnormalities.
- This study reveals a novel role for FAC in cell cycle control through its interaction with cdc2.